Ulacamten
5-[(3,4-difluorophenyl)methyl]-8-(4-methylcyclohexyl)-6,9-dioxo-2,5,8-triazaspiro[3.5]nonane-2-carbaldehyde
Molecular Identity
Ulacamten
5-[(3,4-difluorophenyl)methyl]-8-(4-methylcyclohexyl)-6,9-dioxo-2,5,8-triazaspiro[3.5]nonane-2-carbaldehyde
PubChem CID: 164921580
2D Structure
Properties
C21H25F2N3O3
Molecular Formula
405.40
Molecular Weight
g/mol
405.1864
Exact Mass
Da
2
XLogP
Drug-like (Lipinski: < 5)
60.9
TPSA
Good oral absorption (< 140 A²)
0
H-Bond Donors
5
H-Bond Acceptors
662
Complexity
SMILES
Canonical SMILES
SMILES: CC1CCC(CC1)N2CC(=O)N(C3(C2=O)CN(C3)C=O)CC4=CC(=C(C=C4)F)FIsomeric SMILES
SMILES: CC1CCC(CC1)N2CC(=O)N(C3(C2=O)CN(C3)C=O)CC4=CC(=C(C=C4)F)FSynonyms(20)
2830607-59-3UlacamtenCK-586CK-40215865-(3,4-difluorobenzyl)-8-(trans-4-methylcyclohexyl)-6,9-dioxo-2,5,8-triazaspiro[3.5]nonane-2-carbaldehyde5-[(3,4-difluorophenyl)methyl]-8-(4-methylcyclohexyl)-6,9-dioxo-2,5,8-triazaspiro[3.5]nonane-2-carbaldehydeUlacamteneulacamten [INN]Ulacamten (USAN/INN)ULACAMTEN [USAN]CK-586 (ULACAMTEN)orb2695259orb2695263X325G97HZJCHEMBL6068077
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Ulacamten
Loading drug network...